Nisa Investment Advisors
ZBIO

Nisa Investment Advisors’s Zenas BioPharma ZBIO Stock Holding History

Nisa Investment Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.2K Buy
2,415
+2,300
+2,000% +$51.6K ﹤0.01% 1690
2025
Q4 		$4.18K Hold
115
– – ﹤0.01% 2485
2025
Q3 		$2.55K Hold
115
– – ﹤0.01% 2571
2025
Q2 		$1.11K Buy
115
+87
+311% +$847 ﹤0.01% 2716
2025
Q1 		$221 Buy
+28
New +$219 ﹤0.01% 2915

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Nisa Investment Advisors's ZBIO Position: Q1 2026 in Review

Nisa Investment Advisors increased its Zenas BioPharma (ZBIO) stake by 2,000% in Q1 2026, buying an estimated $51.6K and bringing the position to 2,415 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

Nisa Investment Advisors first reported a position in ZBIO in Q1 2025 and has held it in 5 quarters since. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Nisa Investment Advisors held 2,415 shares of Zenas BioPharma worth $47.2K as of Q1 2026.
  • Nisa Investment Advisors bought 2,300 Zenas BioPharma shares in Q1 2026, an estimated $51.6K.
  • Zenas BioPharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1690 holding.
  • Nisa Investment Advisors first reported a position in Zenas BioPharma in Q1 2025 and has held it in 5 quarters since.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.